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Background/aim: Electrophysiological changes are observed following mechanical stretches due to pressure overload in patients with
severe aortic stenosis (AS). The electrical instability occurs after depolarization and dispersion of repolarization. The aim of this study
was to evaluate changes in ventricular repolarization following transcatheter aortic valve implantation (TAVI).
Materials and methods: The study population included 100 consecutive patients with severe AS that underwent TAVI. Electrocardiography
(ECG) was performed at baseline, immediately after TAVI, and 1 week after TAVI.
Results: The mean age of the patients was 78.2 ± 7.2 years. Thirty-four (34%) of the patients were male and 66 (66%) were female.
Compared to the baseline, mean QT dispersion (QTd) immediately after TAVI and 1 week after TAVI decreased significantly (82.8 ±
26.5, 75.6 ± 25.2, and 65.8 ± 28.3, respectively, P < 0.001). Likewise, compared to the baseline, mean corrected QTd (QTcd) immediately
after TAVI and 1 week after TAVI decreased significantly (84.7 ± 25.2, 76.7 ± 30.8, and 69.1 ± 31.4, respectively, P < 0.001).
Conclusion: QTd is indicative of heterogeneity of ventricular refractoriness and is prolonged in patients with AS. Following TAVI, a
decrease in QTd might reduce the risk of ventricular arrhythmia in patients with severe AS.
Key words: Transcatheter aortic valve implantation, QT dispersion, aortic stenosis

1. Introduction
Degenerative aortic stenosis (AS) is the most common
form of acquired valvular heart disease. Patients with AS
that are treated medically survive 5 years with angina, 3
years with syncope, and 2 years with heart failure (1). In
patients with severe symptomatic AS, arrhythmia is the
most important cause of sudden cardiac death (SCD).
Left ventricular pressure overload leads to hypertrophy
of the left ventricular myocardium. Increased myocardial
hypertrophy with low aortic pressure impairs coronary
blood flow. As a consequence, both hypertrophied and
ischemic heart muscle can cause electrical heterogeneity.
Heterogeneous conduction velocities or repolarization in
different parts of the ventricle via the reentry mechanism
can cause serious ventricular arrhythmias (2,3).
Electrical instability of heart muscle can be detected via
QT dispersion (QTd) using surface electrocardiography
(ECG). QTd is considered a marker of regional
heterogeneity of myocardial repolarization. QTd values
between 40 and 50 ms are considered normal (4), whereas
higher QTd values are indicative of greater ventricular
* Correspondence: huseyinayhan44@yahoo.com

instability (5). Elevated QTd is associated with an
increase in cardiovascular mortality in patients with AS,
hypertrophied cardiomyopathy, myocardial infarction,
dilated cardiomyopathy, and peripheral arterial disease,
and in diabetic patients with autonomic neuropathy (6,7).
The prevalence of complex ventricular arrhythmias is high
in patients with AS. Sudden cardiac death is responsible
for mortality in 30% of patients with severe AS (8). The
risk of SCD is not fully understood in patients with AS,
but left ventricular hypertrophy, myocardial ischemia,
and myocardial fibrosis might be contributing factors (9).
The aim of the present study was to investigate ventricular
repolarization changes following transcatheter aortic valve
implantation (TAVI) in patients with severe AS.
2. Material and methods
The study included 100 consecutive patients with
severe AS that underwent TAVI. All patients also
underwent transthoracic echocardiography (TTE) and
transesophageal echocardiography (TEE) to evaluate valve
morphology, cardiac function, aortic annulus, coronary
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ostium-annulus distance, and calcification. Multislice
computed tomography was performed before TAVI to
determine peripheral vascular anatomy, as well as that of
the aorta, aortic valve, and annulus.
ECG was performed at baseline, immediately after
TAVI, and 1 week after TAVI via 12-lead ECG (Nihon
Kohden Corporation, Cardiofax M Model ECG-1350,
Tokyo, Japan), with each patient lying comfortably in the
supine position. ECG was recorded at a rate of 25 mm s–1
and 10 mm mV–1 gain. The QT interval was measured
from the onset of QRS to the end of the T wave. If a U
wave was present, the QT interval was measured from the
onset of QRS to the deep point of the curve between the T
and U waves. In addition, when T waves were inverted or
biphasic, the end of the T wave point was accepted as when
the trace returned to the isoelectric line. Measurement
of QT duration was performed manually by the same
investigator. To improve accuracy, measurements were
performed with calipers and a magnifying lens for defining
ECG deflection. QTd was defined as the difference between
the minimum and maximum QT interval. QT intervals
were corrected (QTc) using Bazett’s formula (QTc = QT/
(RR)1/2).
TAVI was performed using Edwards Sapien XT balloonexpandable prostheses (Edwards Lifesciences, Irvine, CA,
USA). The study was approved by the Ethics Committee
of Atatürk Education and Training Hospital and, prior to
undergoing TAVI, all patients provided written informed
consent. After clinical stabilization of the patients, they
were discharged with recommendations and outpatient
follow-up was done at 1 week, 1 month, and 6 months.
Follow-up visits included routine physical examination,
ECG, TTE, and functional capacity evaluation.
2.1. Statistics
The statistical analysis was performed using SPSS 17.0
(SPSS Inc., Chicago, IL, USA). The continuous variables
are presented as mean ± standard deviation, and
nonparametric variables are presented as median and
interquartile ranges. Categorical variables are presented as
proportion and percentage. Continuous variables before
and after TAVI were compared between groups using the
paired Student’s t-test for normally distributed variables
including QTd and QTcd values. The level of statistical
significance was accepted as P < 0.05.
3. Results
The study population included 100 consecutive patients
with severe AS that underwent TAVI. The mean age of the
patients was 78.2 ± 7.2 years; 34 (34%) of the patients were
male and 66 (66%) were female. Patient functional capacity
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according to New York Heart Association classification
was class II (n = 7 [7%]), class III (n = 64 [64%]), and class
IV (n = 29 [29%]). Median risk scores according to both
the Society of Thoracic Surgeons and logistic EuroScore
were 7.5 (4–15) and 25.3 (11–39), respectively. Among
the patients, 82% had hypertension, 70% had coronary
artery disease, and 27% had diabetes mellitus. Baseline
characteristics of study population are shown in Table
1. TAVI was performed with a 100% procedural success
rate; however, a second valve implantation procedure was
needed due to technical reasons in 2 patients. After TAVI
Table 1. Baseline demographic characteristics of the study
patients.
Age (years)

78.2 ± 7.2

Males/females (n)

34/66

BMI (kg m–2)

27.9 ± 7.6

NYHA classification
II (%)

7

III (%)

64

IV (%)

29

STS score

7.5 (4–15)

EuroScore

25.3 (11–39)

Comorbid conditions
Hypertension (%)

82

Diabetes mellitus (%)

27

Hyperlipidemia (%)

45

Smoker (%)

19

Peripheral arterial disease (%)

34

Coronary artery disease (%)

70

Echocardiographic parameters
AVA (cm2)

0.62 ± 0.17

Peak gradient (mmHg)

86.3 ± 21.7

Mean gradient (mmHg)

52.5 ± 13.9

LVEF (%)

54.0 ± 14.7

Duration to discharge after procedure (days)

7.4 (4–10)

BMI: Body mass index; NYHA: New York Heart Association;
STS: Society of Thoracic Surgeons; AVA: aortic valve area; LVEF:
left ventricular ejection fraction.
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there were 5 cases of intrahospital mortality due to right
ventricular rupture associated with rapid pacing (n = 2), left
ventricular rupture due to a guidewire in the left ventricle
(n = 1), postoperative bleeding via supraaortic approach
(n = 1), and left main coronary artery obstruction due to
calcification of aortic cusps (n = 1).
The ECG parameters of QTd and corrected QTd (QTcd)
before and after TAVI are presented in Table 2. Mean QTd
at baseline, immediately after TAVI, and 1 week after TAVI
was 82.8 ± 26.5, 75.6 ± 25.2, and 65.8 ± 28.3, respectively.
Mean QTcd at baseline, immediately after TAVI, and 1
week after TAVI was 84.7 ± 25.2, 76.7 ± 30.8, and 69.1 ±
31.4, respectively. Baseline QTd and QTcd were correlated
with the mean aortic valve area (P < 0.001, r: −0.03).
When compared to baseline QTd and QTcd, there was a
significant reduction 1 week after TAVI. QTd and QTcd
values at baseline and immediately after TAVI were 82.8
± 26.5 vs. 75.6 ± 25.2 (P = 0.044) and 84.7 ± 25.2 vs. 76.7
± 30.8 (P = 0.030), respectively. QTd and QTcd values at
baseline and 1 week after TAVI were 82.8 ± 26.5 vs. 65.8 ±
28.3 (P < 0.001) and 84.7 ± 25.2 vs. 69.1 ± 31.4 (P < 0.001),
respectively. QTd and QTcd values are shown in Table 2.
4. Discussion
The present findings show that QTd was elevated in patients
with severe AS and left ventricular hypertrophy. The TAVI
procedure resulted in improvement of QTd and QTcd
values. Age-related calcific AS is a chronic and progressive
disease, and it is the most common type of valvular
heart disease (2%–7% of those aged >65 years) (10). The
asymptomatic latent period varies widely. In patients with
symptomatic severe AS, sudden cardiac death is a frequent
cause of death, but it is rare in asymptomatic patients.
Once symptoms begin the 5-year survival rate is only
15%–50% (10). Valve replacement is the only treatment
modality that affects survival (10).
How and why AS causes SCD remains a controversial
topic. Some researchers think that ventricular tachycardia
due to cardiac muscle hypertrophy can cause SCD (11–
13). In severe AS an increase in mechanical stretch due
to pressure overload can cause myocyte hypertrophy.

In addition, the cardiac renin-angiotensin-aldosterone
system activates gene expression of collagen I-II and
fibronectin. This likely contributes to an increase in total
collagen volume in the myocardium (14). In contrast, AS
impairs coronary blood flow. Hence, hypertrophied and
ischemic heart muscles might cause electrophysiological
changes. Electrical instability is observed as a development
after depolarization and dispersion of repolarization.
Prior studies showed that heterogeneity in repolarization
probably predisposes to such life-threatening arrhythmias
as ventricular tachycardia and ventricular fibrillation
(15,16). Electrical instability of the heart muscle can be
detected via QTd using surface ECG (17).
QTd is a noninvasive marker of ventricular
repolarization heterogeneity. Values between 40 and 50 ms
are considered normal (4), whereas a QTd of >65 ms is
associated with an increased risk of ventricular tachycardia
(14). The pathophysiology of prolonged QTd is not fully
known (18). Arrhythmogenicity depends on modulation
of ion currents, abnormal ventricular structure, and
myocardial ischemia (19). Ventricular dilatation and
fibrosis can affect different areas of the ventricular wall
and cause an increase in dispersion of refractoriness. This
hypothesis is supported by evidence of increased QTd
in patients with hypertrophic cardiomyopathy, acquired
long QT, uremic neuropathy, myocardial infarction, and
hypertension with left ventricular hypertrophy (18).
Darbar et al. reported a reduction of QTd value following
aortic valve surgery and found that resolution of left
ventricular hypertrophy following valve replacement
might be responsible for the significant reduction in QTd
(8). Another reason is the decrease in renin-angiotensinaldosterone levels after ventricular remodeling improves
(14).
QTd is a significant predictor of cardiovascular
mortality. Patients with severe AS and high surgical risk
undergo TAVI, and therefore this group of patients has a
high cardiovascular mortality rate. In the present study,
QTd and QTcd decreased significantly following TAVI;
both QTd and QTcd values progressively decreased, when
compared to baseline values. It could be speculated that

Table 2. QTd and QTcd before and after TAVI, based on ECG.
Electrocardiographic
parameters

Baseline

Immediately after
TAVI

One week
after TAVI

P*

P**

P***

QTd (ms)

82.8 ± 26.5

75.6 ± 25.2

65.8 ± 28.3

0.044

<0.001

0.003

QTcd (ms)

84.7 ± 25.2

76.7 ± 30.8

69.1 ± 31.4

0.030

<0.001

0.014

*Comparison between baseline and immediately after TAVI. **Comparison between baseline and 1 week after TAVI.
***Comparison between immediately after TAVI and 1 week after TAVI.
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the significant decrease in QTd and QTcd values from
baseline to immediately after TAVI is indicative of the
acute hemodynamic effect of TAVI. Costantino et al.
showed that aortic valve implantation via TAVI facilitates
a more rapid recovery of left ventricular geometry and a
greater reduction in left ventricular filling pressure than
conventional surgical aortic valve implantation (20). TAVI
not only improves left ventricular hemodynamics but
also greatly improves ventricular electrical homogeneity

(20). TAVI is a new and proven alternative method for
high surgical risk patients with severe AS. According to
the Partner I-II trial, TAVI is an alternative to standard
surgical aortic valve replacement in inoperable and highrisk surgical candidates (21,22).
In conclusion, QTd is indicative of the heterogeneity of
ventricular refractoriness and is prolonged in AS patients.
Following TAVI the decrease in QTd might decrease the
risk of ventricular arrhythmia in patients with severe AS.
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